Review article · 2022
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions
Journal of Medicinal Chemistry, 65(24), 16033–16061 · Published 12 December 2022 · DOI 10.1021/acs.jmedchem.2c01070
In brief
“Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions” is a 2022 review article by Jindi Huang and 6 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 169 citations as of 21 November 2026, which puts it in the top 1% of works published in 2022 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 169
- Most cited in
- 2025 (55)
- Field-weighted impact
- 2.81
- References
- 205
- Authors
- 7
Abstract
The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is one of the most important intracellular pathways involved in cell proliferation, growth, differentiation, and survival. Therefore, this route is a prospective biological target for treating various human diseases, such as tumors, neurodegenerative diseases, pulmonary fibrosis, and diabetes. An increasing number of clinical… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Huang, J., Chen, L., Wu, J., Ai, D., Zhang, J., Chen, T., & Wang, L. (2022). Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions. Journal of Medicinal Chemistry, 65(24), 16033–16061. https://doi.org/10.1021/acs.jmedchem.2c01070
MLA 9
Huang, Jindi, et al. “Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions.” Journal of Medicinal Chemistry, vol. 65, no. 24, 2022, pp. 16033–16061. https://doi.org/10.1021/acs.jmedchem.2c01070.
Chicago
Huang, Jindi, Liye Chen, Jiangxia Wu, Daiqiao Ai, Jiquan Zhang, Tie‐Gen Chen, and Ling Wang. 2022. “Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions.” Journal of Medicinal Chemistry 65 (24): 16033–16061. https://doi.org/10.1021/acs.jmedchem.2c01070.
Harvard
Huang, J. et al. (2022) ‘Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions’, Journal of Medicinal Chemistry, 65(24), pp. 16033–16061. doi:10.1021/acs.jmedchem.2c01070.
IEEE
J. Huang et al., “Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions,” Journal of Medicinal Chemistry, vol. 65, no. 24, pp. 16033–16061, 2022, doi: 10.1021/acs.jmedchem.2c01070.
BibTeX
@article{huang2022targeting,
title = {{Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions}},
author = {Huang, Jindi and Chen, Liye and Wu, Jiangxia and Ai, Daiqiao and Zhang, Jiquan and Chen, Tie‐Gen and Wang, Ling},
journal = {Journal of Medicinal Chemistry},
year = {2022},
volume = {65},
number = {24},
pages = {16033--16061},
doi = {10.1021/acs.jmedchem.2c01070},
url = {https://doi.org/10.1021/acs.jmedchem.2c01070}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 23 | |
| 2024 | 41 | |
| 2025 | 55 | |
| 2026 | 50 |
Its field-weighted citation impact is 2.81: it has been cited 2.81 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR pathway
- PI3K inhibitors
- AKT inhibitors
- mTOR inhibitors
- allosteric inhibitors
- covalent inhibitors
- PROTACs
- ATP-competitive inhibitors
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Huang, J., Chen, L., Wu, J., Ai, D., Zhang, J., Chen, T., & Wang, L. (2022). Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions. Journal of Medicinal Chemistry, 65(24), 16033–16061. https://doi.org/10.1021/acs.jmedchem.2c01070
How many times has this paper been cited?
169 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Jindi Huang, Liye Chen, Jiangxia Wu, Daiqiao Ai, Jiquan Zhang, Tie‐Gen Chen, Ling Wang.
What is the DOI of this paper?
10.1021/acs.jmedchem.2c01070, permanently at https://doi.org/10.1021/acs.jmedchem.2c01070. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.